King Thomas Braxton
- SEC CIK
- 0001279309
No open-market purchases or sales filed in the past year.
Current role at each company
- ACHV Achieve Life Sciences, Inc.Directoras of Sep 8, 2025
- TFFP TFF Pharmaceuticals, Inc.Directoras of Jul 8, 2024
- STSA Satsuma Pharmaceuticals, Inc.Directoras of Jun 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists King Thomas Braxton as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACHV Achieve Life Sciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2025 (view filing) | Sep 4 | 4 days | King Thomas BraxtonDirector | SSale | −139.9K | $2.77 | −$387.4K | −30.7%315.1K after |